Boston Scientific Corporation (BSX) is listed on NYSE in Medical Device Stocks. It is $46.83, +0.34%, with a $67.9B market cap. RSI is 45.9, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 45.9 Neutral
Market Cap $67.9B
Volume 12.6M
Fundamentals — 10-Q Q2 2026
Revenue $10.6B
Net Income --
EPS $1.51
Gross Margin 70.1%
Operating Margin 21.4%
P/E Ratio 31.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Morano Susan E | Director | Buy | 2,040 | $49.22 | $100,408 | 2026 Aug 25 |
| Habiger David C | Director | Buy | 2,100 | $47.59 | $99,937 | 2026 Aug 5 |
| Habiger David C | Director | Buy | 1,182 | $48.13 | $56,887 | 2026 Aug 4 |
| Mahoney Michael F | Chairman, President & CEO | Buy | 186,240 | $48.33 | $9.0M | 2026 Aug 3 |
| Ludwig Edward J | Director | Buy | 5,000 | $45.48 | $227,400 | 2026 Jul 31 |
| Pegus Cheryl | Director | Buy | 1,770 | $56.49 | $99,987 | 2026 May 20 |
| Ludwig Edward J | Director | Buy | 3,580 | $56.68 | $202,914 | 2026 May 20 |
| Habiger David C | Director | Buy | 4,450 | $56.43 | $251,098 | 2026 May 20 |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.8M | 2025 Dec 1 |
| Zane Ellen M | Director | Sell | 12,891 | $98.28 | $1.3M | 2025 Nov 6 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $99.47 | $5.0M | 2025 Nov 3 |
| Zane Ellen M | Director | Sell | 12,891 | $101.38 | $1.3M | 2025 Oct 28 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $98.47 | $4.9M | 2025 Oct 1 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $105.43 | $5.3M | 2025 Sep 2 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $104.63 | $5.2M | 2025 Aug 1 |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $104.63 | $1.8M | 2025 Aug 1 |
| Fujimori Yoshiaki | Director | Sell | 2,901 | $106.99 | $310,378 | 2025 Jul 29 |
| Ludwig Edward J | Director | Sell | 4,000 | $106.03 | $424,120 | 2025 Jul 25 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5.3M | 2025 Jul 1 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5.8M | 2025 Jun 4 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $372.55 | 49.7 | $131.6B |
| | $174.34 | 51.8 | $89.9B |
| | $240.31 | 72.0 | $34.7B |
| | $35.28 | 47.1 | $29.6B |
| | $90.19 | 55.1 | $52.0B |
| | $90.82 | 63.9 | $34.3B |
Take BSX further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BSX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Boston Scientific Corporation next reports.
Set alerts on BSX
Get notified when Boston Scientific Corporation hits your price targets or technical conditions are met.
Get Started Free